2025.1 Primary exam written results

The following candidates have met the criteria for invitation to the primary viva examination in May 2025.
This is based on their performance in the written component of the primary examination held on 4 March 2025.
502 | 545 | 591 | 636 | 687 | 732 |
503 | 546 | 592 | 638 | 690 | 733 |
504 | 548 | 593 | 639 | 691 | 735 |
505 | 549 | 595 | 644 | 692 | 736 |
506 | 550 | 596 | 646 | 693 | 740 |
507 | 551 | 597 | 648 | 694 | 741 |
508 | 552 | 598 | 650 | 695 | 742 |
509 | 553 | 599 | 651 | 696 | 744 |
510 | 554 | 602 | 652 | 699 | 745 |
511 | 555 | 604 | 654 | 701 | 749 |
512 | 556 | 605 | 656 | 702 | 750 |
513 | 559 | 607 | 658 | 703 | 752 |
514 | 562 | 608 | 660 | 706 | 754 |
515 | 563 | 610 | 661 | 707 | 756 |
516 | 564 | 611 | 662 | 708 | 757 |
517 | 565 | 612 | 663 | 709 | 758 |
520 | 566 | 613 | 664 | 710 | 759 |
523 | 567 | 614 | 665 | 711 | 760 |
524 | 568 | 617 | 667 | 712 | 761 |
526 | 569 | 618 | 668 | 713 | 762 |
527 | 570 | 619 | 669 | 715 | 763 |
528 | 572 | 620 | 670 | 716 | 764 |
529 | 573 | 621 | 673 | 717 | 765 |
530 | 574 | 622 | 674 | 719 | 766 |
531 | 575 | 623 | 675 | 720 | 768 |
533 | 576 | 624 | 677 | 721 | 769 |
534 | 577 | 625 | 678 | 724 | 770 |
536 | 579 | 626 | 679 | 725 | 771 |
537 | 580 | 627 | 680 | 726 | 772 |
538 | 582 | 628 | 681 | 727 | 773 |
539 | 583 | 629 | 682 | 728 | 774 |
540 | 585 | 630 | 683 | 729 | 775 |
542 | 586 | 634 | 685 | 730 | 776 |
543 | 590 | 635 | 686 | 731 |
|
You might also be interested in...

Based on new evidence from clinical studies and to make recommendations clearer, clinical practice recommendations for patients taking GLP-1 RA and dual GLP-1/GIP RAs prior to anaesthesia or sedation have been updated.

Refer to the attached summary document for the specific measures from the 2025-26 Federal Budget relating to ANZCA and our anaesthesia and pain medicine operating environment.

Reynard Health is conducting a Critical Recall of 0.5% Chlorhexidine swab sticks foam, large foam swab sticks and prep pads 6cm x 6cm and is also conducting a Critical Quarantine of a broader range of products.